Found: 9
Select item for more details and to access through your institution.
A Phase II Trial of Inotuzumab Ozogamicin Combined with Mini-HyperCVD as Salvage Therapy for Relapsed/Refractory ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S264, doi. 10.1016/j.clml.2017.07.032
- By:
- Publication type:
- Article
Safety and Efficacy of Blinatumomab in Combination with a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-Positive Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S265, doi. 10.1016/j.clml.2017.07.033
- By:
- Publication type:
- Article
Prognostic Index and Nomogram for Overall Survival (OS) of Adult Patients with Philadelphia-negative B-cell ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S13, doi. 10.1016/j.clml.2016.07.020
- By:
- Publication type:
- Article
A Phase I/II Trial of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy as Frontline Therapy for Older Patients with ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S15, doi. 10.1016/j.clml.2016.07.023
- By:
- Publication type:
- Article
Outcomes after Blinatumomab Failure in Patients with Relapsed/ Refractory (R/R) B-cell ALL (ALL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S12, doi. 10.1016/j.clml.2016.07.019
- By:
- Publication type:
- Article
Propensity Score Analysis: Hyper-CVAD (HCVAD) + Ponatinib vs. HCVAD + Dasatinib in Patients (Pts) with Philadelphia Chromosome-Positive (Ph+) ALL (ALL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S9, doi. 10.1016/j.clml.2016.07.016
- By:
- Publication type:
- Article
Complex Karyotype and Low Hypodiploidy/Near Triploidy are Adverse Prognostic Factors in Adult ALL (ALL) Independent of MRD Status.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S7, doi. 10.1016/j.clml.2016.07.011
- By:
- Publication type:
- Article
Energy Harvesting Capability of Lipid-Merocyanine Macromolecules: A New Design and Performance Model Development.
- Published in:
- Photochemistry & Photobiology, 2014, v. 90, n. 3, p. 517, doi. 10.1111/php.12193
- By:
- Publication type:
- Article
Prognostic factors for progression in patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2648, doi. 10.1002/cncr.33529
- By:
- Publication type:
- Article